The high-affinity IgE receptor (FcεRI): From physiology to pathology

Annual Review of Immunology

Volumn 17, Issue , 1999, Pages 931-972

  Kinet, Jean Pierre ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Atopy; Receptor; Signaling

Indexed keywords

ALLERGEN; AUTOANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTATION; ATOPY; BETA CHAIN; BINDING AFFINITY; CALCIUM TRANSPORT; MOLECULAR INTERACTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; TISSUE DISTRIBUTION;

ANIMALS; ANTIGEN PRESENTATION; AUTOANTIBODIES; GENE EXPRESSION REGULATION; HUMANS; HYPERSENSITIVITY; MICE; MODELS, MOLECULAR; PARASITES; PROTEIN CONFORMATION; PROTEIN-TYROSINE KINASES; RATS; RECEPTORS, IGE; SIGNAL TRANSDUCTION; URTICARIA;

EID: 0032970154     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.17.1.931     Document Type: Review

References (251)

1. Metzger H, Alcarez G, Hohman R, Kinet JP, Pribluda V, Quarto R. 1986. The receptor with high affinity for immunoglobulin E. Annu. Rev. Immunol. 4:419-70
2. Ravetch JV, Kinet JP. 1991. Fc receptors. Annu. Rev. Immunol. 9:457-92
3. Ra C, Jouvin MH, Blank U, Kinet JP. 1989. A macrophage Fc gamma receptor and the mast cell receptor for IgE share an identical subunit. Nature 341:752-54
4. Hibbs ML, Selvaraj P, Carpen O, Springer TA, Kuster H, Jouvin MH, Kinet JP. 1989. Mechanisms for regulating expression of membrane isoforms of Fc gamma RIII (CD16). Science 246:1608-11
5. Kurosaki T, Ravetch JV. 1989. A single amino acid in the glycosyl phosphatidylinositol attachment domain determines the membrane topology of Fc gamma RIII [published erratum appears in Nature 1990, Jan. 25; 343 (6256):390]. Nature 342:805-7
6. Orloff DG, Ra CS, Frank SJ, Klausner RD, Kinet JP. 1990. Family of disulphide-linked dimers containing the zeta and eta chains of the T-cell receptor and the gamma chain of Fc receptors. Nature 347:189-91
7. Blank U, Ra C, Miller L, White K, Metzger H, Kinet JP. 1989. Complete structure and expression in transfected cells of high affinity IgE receptor. Nature 337:187-89
8. Ra C, Jouvin MH, Kinet JP. 1989. Complete structure of the mouse mast cell receptor for IgE (Fc epsilon RI) and surface expression of chimeric receptors (rat-mouse-human) on transfected cells. J. Biol. Chem. 264:15323-27
9. Kinet JP, Alcaraz G, Leonard A, Wank S, Metzger H. 1985. Dissociation of the receptor for immunoglobulin E in mild detergents. Biochemistry 24:4117-24
10. Kinet JP, Quarto R, Perez-Montfort R, Metzger H. 1985. Noncovalently and covalently bound lipid on the receptor for immunoglobulin E. Biochemistry 24:7342-48
11. Kinet JP, Metzger H, Hakimi J, Kochan J. 1987. A cDNA presumptively coding for the alpha subunit of the receptor with high affinity for immunoglobulin E [published erratum appears in Biochemistry 1988 Nov. 15; 27(23):8694]. Biochemistry 26:4605-10
12. Shimizu A, Tepler I, Benfey PN, Berenstein EH, Siraganian RP, Leder P. 1988. Human and rat mast cell high-affinity immunoglobulin E receptors: characterization of putative alpha-chain gene products. Proc. Natl. Acad. Sci. USA 85:1907-11
13. Kochan J, Pettine LF, Hakimi J, Kishi K, Kinet JP. 1988. Isolation of the gene coding for the alpha subunit of the human high affinity IgE receptor. Nucleic Acids Res. 16:3584
14. Letourneur O, Sechi S, Willette-Brown J, Robertson MW, Kinet JP. 1995. Glycosylation of human truncated Fc epsilon RI alpha chain is necessary for efficient folding in the endoplasmic reticulum. J. Biol. Chem. 270:8249-56
15. Kinet JP, Blank U, Ra C, White K, Metzger H, Kochan J. 1988. Isolation and characterization of cDNAs coding for the beta subunit of the high-affinity receptor for immunoglobulin E. Proc. Natl. Acad. Sci. USA 85:6483-7
16. Kurosaki T, Gander I, Wirthmueller U, Ravetch JV. 1992. The beta subunit of the Fc epsilon RI is associated with the Fc gamma RIII on mast cells. J. Exp. Med. 175:447-51
17. Lanier LL, Yu G, Phillips JH. 1989. Coassociation of CD3zeta with a receptor (CD16) for IgG Fc on human natural killer cells. Nature 342:803-5
18. Anderson P, Caligiuri M, Ritz J, Schlossman SF. 1989. CD3-negative natural killer cells express zeta TCR as part of a novel molecular complex. Nature 341:159-62
19. Anderson P, Caligiuri M, O'Brien C, Manley T, Ritz J, Schlossman SF. 1990. Fc gamma receptor type III (CD16) is included in the zeta NK receptor complex expressed by human natural killer cells, Proc. Natl. Acad. Sci. USA 87:2274-78
20. Kinet JP. 1992. The gamma-zeta dimers of Fc receptors as connectors to signal transduction. Curr. Opin. Immunol. 4:43-48
21. Ernst LK, Duchemin AM, Anderson CL. 1993. Association of the high-affinity receptor for IgG (Fc gamma RI) with the gamma subunit of the IgE receptor. Proc. Natl. Acad. Sci. USA 90:6023-27
22. Scholl PR, Geha RS. 1993. Physical association between the high-affinity IgG receptor (Fc gamma RI) and the gamma subunit of the high-affinity IgE receptor (Fc epsilon RI gamma). Proc. Natl. Acad. Sci. USA 90:8847-50
23. Pfefferkorn LC, Yeaman GR. 1994. Association of IgA-Fc receptors (Fc alpha R) with Fc epsilon RI gamma 2 subunits in U937 cells. Aggregation induces the tyrosine phosphorylation of gamma 2. J. Immunol. 153:3228-36
24. Morton HC, van den Herik-Oudijk IE, Vossebeld PA, Snijders A, Verhoeven AJ, Capel PJ, van de Winkel JG. 1995. Functional association between the human myeloid immunoglobulin A Fc receptor (CD89) and FcR gamma chain. Molecular basis for CD89/FcR gamma chain association. J. Biol. Chem. 270:29781-87
25. Gibbins J, Asselin J, Farndale R, Barnes M, Law CL, Watson SP. 1996. Tyrosine phosphorylation of the Fc receptor gamma-chain in collagen-stimulated platelets. J. Biol. Chem. 271:18095-99
26. Gibbins JM, Okuma M, Farndale R, Barnes M, Watson SP. 1997. Glycoprotein VI is the collagen receptor in platelets which underlies tyrosine phosphorylation of the Fc receptor gamma-chain. FEBS Lett. 413:255-59
27. Tsuji M, Ezumi Y, Arai M, Tukayama H. 1997. A novel association of Fc receptor gamma-chain with glycoprotein VI and their co-expression as a collagen receptor in human platelets. J. Biol Chem. 272:23528-31
28. Letourneur F, Hennecke S, Demolliere C, Cosson P. 1995. Steric masking of a dilysine endoplasmic reticulum retention motif during assembly of the human high affinity receptor for immunoglobulin E. J. Cell Biol. 129:971-78
29. Miller L, Blank U, Metzger H, Kinet JP. 1989. Expression of high-affinity binding of human immunoglobulin E by transfected cells. Science 244:33437
30. Kuster H, Thompson H, Kinet JP. 1990. Characterization and expression of the gene for the human Fc receptor gamma subunit. Definition of a new gene family. J. Biol. Chem. 265:6448-52
31. Wang B, Rieger A, Kilgus O, Ochiai K, Maurer D, Fodinger D, Kinet JP, Stingl G. 1992. Epidermal Langerhans cells from normal human skin bind monomeric IgE via Fc epsilon RI. J. Exp. Med. 175:1353-65
32. Bieber T, de la Salle H, Wollenberg A, Hakimi J, Chizzonite R, Ring J, Hanau D, de la Salle C. 1992. Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI). J. Exp. Med. 175:1285-90
33. Gounni AS, Lamkhioued B, Ochiai K, Tanaka Y, Delaporte E, Capron A, Kinet JP, Capron M. 1994. High-affinity IgE receptor on cosinophils is involved in defence against parasites. Nature 367:183-6
34. Maurer D, Fiebiger E, Reininger B, Wolff-Winiski B, Jouvin MH, Kilgus O, Kinet JP, Stingl G. 1994. Expression of functional high affinity immunoglobulin E receptors (Fc epsilon RI) on monocytes of atopic individuals. J. Exp. Med. 179:745-50
35. Maurer D, Fiebiger S, Ebner C, Reininger B, Fischer GF, Wichlas S, Jouvin MH, Schmitt-Egenolf M, Kraft D, Kinet JP, Stingl G. 1996. Peripheral blood dendritic cells express Fc epsilon RI as a complex composed of Fc epsilon RI alpha-and Fe epsilon RI gamma-chains and can use this receptor for IgE-mediated allergen presentation. J. Immunol. 157:607-16
36. Joseph M, Gounni AS, Kusnierz JP, Vorng H, Sarfati M, Kinet JP, Tonnel AB, Capron A, Capron M. 1997. Expression and functions of the high-affinity IgE receptor on human platelets and megakaryocyte precursors. Eur. J. Immunol. 27:2212-18
37. Tanaka Y, Takenaka M, Matsunaga Y, Okada S, Anan S, Yoshida H, Ra C. 1995. High affinity IgE receptor (Fc epsilon RI) expression on eosinophils infiltrating the lesions and mite patchtested sites in atopic dermatitis. Arch. Dermatol. Res. 287:712-17
38. Humbert M, Grant JA, Taborda-Barata L, Durham SR, Pfister R, G Menz, Barkans J, Ying S, Kay AB. 1996. High-affinity IgE receptor (Fc epsilon RI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma. Am. J. Respir. Crit. Care Med. 153:1931-37
39. Sihra BS, Kon OM, Grant JA, Kay AB. 1997. Expression of high-affinity IgE receptors (Fc epsilon RI) on peripheral blood basophils, monocytes, and eosinophils in atopic and nonatopic subjects: relationship to total serum IgE concentrations. J. Allergy Clin. Immunol. 99:699-706
40. Rajakulasingam K, Durham SR, O'Brien F, Humbert M, Barata LT, Reece L, Kay AB, Grant JA. 1997. Enhanced expression of high-affinity IgE receptor (Fc epsilon RI) alpha chain in human allergen-induced rhinitis with co-localization to mast cells, macrophages, eosinophils, and dendritic cells. J. Allergy Clin. Immunol. 100:78-86
41. Ying S, Barata LT, Meng Q, Grant JA, Barkans J, Durham SR, Kay AB. 1998. High-affinity immunoglobulin E receptor (Fc epsilon RI)-bearing eosinophils, mast cells, macrophages and Langerhans' cells in allergen-induced latephase cutaneous reactions in atopic subjects. Immunology 93:281-88
42. Riske F, Hakimi J, Mallamaci M, Griffin M, Pilson B, Tobkes N, Lin P, Danho W, Kochan J, Chizzonite R. 1991. High affinity human IgE receptor (Fc epsilon RI). Analysis of functional domains of the alpha-subunit with monoclonal antibodies. J. Biol. Chem. 266:11245-51
43. Tepler I, Shimizu A, Leder P. 1989. The gene for the rat mast cell high affinity IgE receptor alpha chain. Structure and alternative mRNA splicing patterns. J. Biol. Chem. 264:5912-15
44. Ye ZS, Kinet JP, Paul WE. 1992. Structure of the gene for the alpha-chain of the mouse high affinity receptor for IgE (Fc epsilon RI). J. Immunol. 49:897-900
45. Pang J, Taylor GR, Munroe DG, Ishaque A, Fung-Leung WP, Lau CY, Liu FT, Zhou L. 1993. Characterization of the gene for the human high affinity IgE receptor (Fc epsilon RI) alpha-chain. J. Immunol. 151:6166-74
46. Dombrowicz D, Brini AT, Flamand V, Hicks E, Snouwaert JN, Kinet JP, Koller BH. 1996. Anaphylaxis mediated through a humanized high affinity IgE receptor. J. Immunol. 157:1645-51
47. Dombrowicz D, Lin S, Flamand V, Brini AT, Koller BH, Kinet JP. 1998. Allergy-associated FcR beta is a molecular amplifier of IgE-and IgG-mediated in vivo responses. Immunity 8:517-29
48. Fung-Leung WP, De Sousa-Hitzler J, Ishaque A, Zhou L, Pang J, Ngo K, Panakos JA, Chourmouzis E, Liu FT, Lau CY. 1996. Transgcnic mice expressing the human high-affinity immunoglobulin (Ig) E receptor alpha chain respond to human IgE in mast cell degranulation and in allergic reactions. J. Exp. Med. 183:49-56
49. Lin S, Cicala C, Scharenberg AM, Kinet JP. 1996. The Fc(epsilon)RI beta subunit functions as an amplifier of Fc(epsilon)RI gamma-mediated cell activation signals. Cell 85:985-95
50. Hakimi J, Seals C, Kondas JA, Pettine L, Danho W, Kochan J. 1990. The alpha subunit of the human IgE receptor (FcERI) is sufficient for high affinity IgE binding. J. Biol. Chem. 265:22079-81
51. Blank U, Ra CS, Kinet JP. 1991. Characterization of truncated alpha chain products from human, rat, and mouse high affinity receptor for immunoglobulin E. J. Biol. Chem. 266:2639-46
52. Alber G, Miller L, Jelsema CL, Varin-Blank N, Metzger H. 1991. Structure-function relationships in the mast cell high affinity receptor for IgE. Role of the cytoplasmic domains and of the beta subunit. J. Biol. Chem. 266:22613-20
53. Sutton BJ, Gould HJ. 1993. The human IgE network. Nature 366:421-28
54. Helm B, Marsh P, Vercelli D, Padlan E, Gould HJ, Geha R. 1988. The mast cell binding site on human immunoglobulin E. Nature 331:180-83
55. Helm B, Kebo D, Vercelli D, Glovsky MM, Gould H, Ishizaka K, Geha R, Ishizaka T. 1989. Blocking of passive sensitization of human mast cells and basophil granulocyles with IgE antibodies by a recombinant human epsilon-chain fragment of 76 amino acids. Proc. Natl. Acad. Sci. USA 86:9465-69
56. Schwarzbaum S, Nissim A, Alkalay I, Ghozi MC, Schindler DG, Bergman Y, Eshhar Z. 1989. Mapping of murine IgE epitopes involved in IgE-Fcε receptor interactions. Eur. J. Immunol. 19:1015-23
57. Weetall M, Shopes B, Holowka D, Baird B. 1990. Mapping the site of interaction between murine IgE and its high affinity receptor with chimeric Ig. J. Immunol. 145:3849-54
58. Nissim A, Jouvin M-H, Eshhar Z. 1991. Mapping of the high affinity Fcε receptor binding site to the third constant region domain of IgE. EMBO J. 10:101-7
59. Basu M, Hakimi J, Dharm E, Kondas JA, Tsien W-H, Pilson RS, Lin P, Gilfillan A, Haring P, Braswell EH, Nettleton MY, Kochan JP. 1993. Purification and characterization of human recombinant IgE-Fc fragments that bind to the human high affinity IgE receptor. J. Biol. Chem. 268:13118-27
60. Nissim A, Schwarzbaum S, Siraganian R, Eshhar Z. 1993. Fine specificity of the IgE interaction with the low and high affinity Fc receptor. J. Immunol. 150:1365-74
61. Presta L, Shields R, O'Connell L, Lahr S, Porter J, Gorman C, Jardieu P. 1994. The binding site on human immunoglobulin E for its high affinity receptor. J. Biol. Chem. 269:26368-73
62. Helm BA, Sayers I, Higginbottom A, Machado DC, Ling Y, Ahmad K, Padlan EA, Wilson AP. 1996. Identification of the high affinity receptor binding region in human immunoglobulin E. J. Biol. Chem. 271:7494-7500
63. Keown MB, Henry AJ, Ghirlando R, Sutton BJ, Gould HJ. 1998. Thermo-dynamics of the interaction of human immunoglobulin E with its high-affinity receptor Fc epsilon RI. Biochemistry 37:8863-69
64. Sechi S, Roller PP, Willette-Brown J, Kinet JP. 1996. A conformational rearrangement upon binding of IgE to its high affinity receptor. J. Biol. Chem. 271:19256-63
65. Williams AF, Davis SJ, He Q, Barclay AN. 1989. Structural diversity in domains of the immunoglobulin superfamily, Cold Spring Harbor Symp. Quant. Bio. 54:637
66. Padlan EA, Helm BA. 1992. A modeling study of the α-subunit of human high-affinity receptor for immunoglobulin E receptor. 2:129-43
67. Hogarth PM, Hulett MD, Ierino FL, Tate B, Powell MS, Brinkworth RI. 1992. Identification of the immunoglobulin binding regions (IBR) of FcγRII and FcεRI. Immunol. Rev. 125:21-35
68. Hulett MD, McKenzie IFC, Hogarth PM. 1993. Chimeric Fc receptors identify immunoglobulin-binding regions in human FcγRII and FcεRI. Eur. J. Immunol. 23:640-45
69. Mallamaci MA, Chizzonite R, Griffin M, Nettleton M, Hakimi J, Tsien W-H, Kochan JP. 1993. Identification of sites on the human FcεRIα subunit which are involved in binding human and rat IgE. J. Biol. Chem. 268:22076-83
70. Robertson MW. 1993. Phage and Escherichia coli expression of the human high affinity immunoglobulin E receptor α-subunit ectodomain. Domain localization of the IgE-binding site. J. Biol. Chem. 268:12736-43
71. Scarselli E, Esposito G, Traboni C. 1993. Receptor phage: display of functional domains of the high affinity IgE receptoron the M13 phage surface. FEBS Lett. 329:223-26
72. McDonnell JM, Beavil AJ, Mackay GA, Jameson BA, Korngold R, Gould HJ, Sutton BJ. 1996. Structure based design and characterization of peptides that inhibit IgE binding to its high-affinity receptor. Nature Struc. Biol. 3:419-26
73. Cook JP, Henry AJ, McDonnell JM, Owens RJ, Sutton BJ, Gould HJ. 1997. Identification of contact residues in the IgE binding site of human Fc epsilon RI alpha. Biochemistry 36:15579-88
74. Dombrowicz D, Flamand V, Brigman KK, Koller BH, Kinet JP. 1993. Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor alpha chain gene. Cell 75:969-76
75. Jankovic D, Kullberg MC, Dombrowicz D, Barbieri S, Caspar P, Wynn TA, Paul WE, Checver AW, Kinet JP, Sher A. 1997. Fc epsilonRI-deficient mice infected with Schistosoma mansoni mount normal Th2-type responses while displaying enhanced liver pathology. J. Immunol. 159:1868-75
76. Matsuda H, Watanabe N, Kiso Y, Hirota S, Ushio H, Kannan Y, Azuma M, Koyama H, Kitamura Y. 1990. Necessity of IgE antibodies and mast cells for manifestation of resistance against larval Haemaphysalis longicornis ticks in mice. J. Immunol. 144:259-62
77. Matsuda H, Fukui K, Kiso Y, Kitamura Y. 1985. Inability of genetically mast cell-deficient W/Wv mice to acquire resistance against larval Haemaphysalis longicornis ticks. J. Parasitol. 71:443-48
78. Matsuda H, Nakano T, Kiso Y, Kitamura Y. 1987. Normalization of anti-tick response of mast cell-deficient W/Wv mice by intracutaneous injection of cultured mast cells. J. Parasitol. 73:155-60
79. Maurer D, Ebner C, Reininger B, Fiebiger E, Kraft D, Kinet JP, Stingl G. 1995. The high affinity IgE receptor (Fc epsilon RI) mediates IgE-dependent allergen presentation. J. Immunol. 154:6285-90
80. Gounni AS, Lamkhioued B, Delaporte E, Dubost A, Kinet JP, Capron A, Capron M. 1994. The high-affinity IgE receptor on eosinophils: from allergy to parasites or from parasites to allergy? J. Allergy Clin. Immunol. 94:1214-16
81. Pritchard DI, Hewitt C, Moqbel R. 1997. The relationship between immunological responsiveness controlled by T-helper 2 lymphocytes and infections with parasitic helminths. Parasitology 115:S33-44
82. Dunne DW, Butterworth AE, Fulford AJ, Kariuki HC, Langley JG, Ouma JH, Capron A, Pierce RJ, Sturrock RF. 1992. Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur. J. Immunol. 22:1483-94
83. Hagan P, Blumenthal UJ, Dunn D, Simpson AJ, Wilkins HA. 1991. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 349:243-45
84. Rihet P, Demeure CE, Bourgois A, Prata A, Dessein AJ. 1991. Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels. Eur. J. Immunol. 21:2679-86
85. Allen JE, Maizels RM. 1996. Immunology of human helminth infection. Int. Arch. Allergy Immunol. 109:3-10
86. ISAAC Steering Committee. 1998. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee [see comments]. Lancet 351:1225-32
87. Malveaux FJ, Conroy MC, Adkinson NF Jr, Lichtenstcin LM. 1978. IgE receptors on human basophils. Relationship to serum IgE concentration. J. Clin. Invest. 62:176-81
88. Furuichi K, Rivera J, Isersky C. 1985. The receptor for immunoglobulin E on rat basophilic leukemia cells: effect of ligand binding on receptor expression. Proc. Natl. Acad. Sci. USA 82:1522-25
89. Quarto R, Kinet JP, Metzger H. 1985. Coordinate synthesis and degradation of the alpha-, beta-and gamma-subunits of the receptor for immunoglobulin E. Mol. Immunol. 22:1045-51
90. Yamaguchi M, Lantz CS, Oettgen HC, Katona IM, Fleming T, Miyajima I, Kinet JP, Galli SJ. 1997. IgE enhances mouse mast cell Fc(epsilon)RI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J. Exp. Med. 185:663-72
91. Lantz CS, Yamaguchi M, Oettgen HC, Katona IM, Miyajima I, Kinet JP, Galli SJ. 1997. IgE regulates mouse basophil Fc epsilon RI expression in vivo. J. Immunol. 158:2517-21
92. Yano K, Yamaguchi M, de Mora F, Lantz CS, Butterfield JH, Costa JJ, Galli SJ. 1997. Production of macrophage inflammatory protein-1 alpha by human mast cells: increased anti-IgE-dependent secretion after IgE-dependent enhancement of mast cell IgE-binding ability. Lab. Invest. 77:185-93
93. MacGlashan D Jr, McKenzie-White J, Chichester K, Bochner BS, Davis FM, Schroeder JT, Lichtenstein LM. 1998. In vitro regulation of Fc epsilon RI alpha expression on human basophils by IgE antibody. Blood 91:1633-43
94. MacGlashan DW Jr, Bochner BS, Adelman DC, Jardieu PM, Togias A, McKenzie-White J, Sterbinsky SA, Hamilton RG, Lichtenstein LM. 1997. Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J. Immunol. 158: 1438-45
95. Rottem M, Barbieri S, Kinet JP, Metcalfe DD. 1992. Kinetics of the appearance of Fc epsilon RI-bearing cells in interleukin-3-dependent mouse bone marrow cultures: correlation with histamine content and mast cell maturation. Blood 79:972-80
96. Toru H, Ra C, Nonoyama S, Suzuki K, Yata J, Nakahata T. 1996. Induction of the high-affinity IgE receptor (Fc epsilon RI) on human mast cells by IL-4. Int. Immunol. 8:1367-73
97. Xia HZ, Du Z, Craig S, Klisch G, Noben-Trauth N, Kochan JP, Huff TH, Irani AM, Schwartz LB. 1997. Effect of recombinant human IL-4 on tryptase, chymase, and Fc epsilon receptor type I expression in recombinant human stem cell factor-dependent fetal liver-derived human mast cells. J. Immunol. 159:2911-21
98. Brini AT, Lee GM, Kinet JP. 1993. Involvement of Alu sequences in the cell-specific regulation of transcription of the gamma chain of Fc and T cell receptors. J. Biol. Chem. 268:1355-61
99. Klausner RD, Lippincott-Schwartz J, Bonifacino JS. 1990. The T cell antigen receptor: insights into organelle biology, Annu. Rev. Cell Biol. 6:403-31
100. Ryan JJ, Kinzer CA, Paul WE. 1995. Mast cells lacking the high affinity immunoglobulin E receptor are deficient in Fc epsilon RI gamma messenger RNA. J. Exp. Med. 182:567-74
101. Kraft S, Wessendorf JH, Hanau D,
102. Bieber T. 1998. Regulation of the high affinity receptor for IgE on human epidermal Langcrhans cells. J. Immunol. 161:1000-6
103. Cookson WO, Sharp PA, Faux JA, Hopkin JM. 1989. Linkage between immunoglobulin E responses underlying asthma and rhinitis and chromosome 11q. Lancet 1:1292-95
104. Young RP, Sharp PA, Lynch Jr, Faux JA, Lathrop GM, Cookson WO, Hopkin JM. 1992. Confirmation of genetic linkage between atopic IgE responses and chromosome 11q13. J. Med. Genet. 29:236-38
105. Marsh DG, Meyers DA. 1992. A major gene for allergy-factor fancy? [news]. Nat. Genet. 2:252-54
106. Lympany P, Welsh K, MacCochrane G, Kemeny DM, Lee TH. 1992. Genetic analysis using DNA polymorphism of the linkage between chromosome 11q13 and atopy and bronchial hyperresponsiveness to methacholine. J. Allergy Clin. Immunol. 89:619-28
107. Amelung PJ, Panhuysen CI, Postma DS, Levitt RC, Koeter GH, Francomano CA, Bleecker ER, Meyers DA. 1992. Atopy and bronchial hyperresponsiveness: exclusion of linkage to markers on chromosomes 11q and 6p. Clin. Exp. Allergy 22:1077-84
108. Rich SS, Roitman-Johnson B, Greenberg B, Roberts S, Blumenthal MN. 1992. Genetic analysis of atopy in three large kindreds: no evidence of linkage to D1 IS97. Clin. Exp. Allergy 22:1070-76
109. Sandford AJ, Shirakawa T, Moffatt MF, Daniels SE, Ra C, Faux JA, Young RP, Nakamura Y, Lathrop GM, Cookson WO, et al. 1993. Localisation of atopy and beta subunit of high-affinity IgE receptor (Fc epsilon RI) on chromosome 11q [see comments]. Lancet 341:332-34
110. Shirakawa T, Hashimoto T, Furuyama J, Takeshita T, Morimoto K. 1994. Linkage between severe atopy and chromosome 11q13 in Japanese families. Clin. Genet. 46:228-32
111. Brereton HM, Ruffin RE, Thompson PJ, Turner DR. 1994. Familial atopy in Australian pedigrees: adventitious linkage to chromosome 8 is not confirmed nor is there evidence of linkage to the high affinity IgE receptor. Clin. Exp. Allergy 24:868-77
112. Watson M, Lawrence S, Collins A, Beasley R, Doull I, Begishvili B, Lampe F, Holgate ST, Morton NE. 1995. Exclusion from proximal 11q of a common gene with megaphcnic effect on atopy. Ann. Hum. Genet. 59:403-11
113. van Herwerden L, Harrap SB, Wong ZY, Abramson MJ, Kutin JJ, Forbes AB, Raven J, Lanigan A, Walters EH. 1995. Linkage of high-affinity IgE receptor gene with bronchial hyperreactivity, even in absence of atopy [see comments]. Lancet 346:1262-65
114. Doull IJ, Lawrence S, Watson M, Begishvili T, Beasley RW, Lampe F, Hoigate T, Morton NE. 1996. Allelic association of gene markers on chromosomes 5q and 11q with atopy and bronchial-hyperresponsiveness. Am. J. Respir. Crit. Care Med. 153:1280-84
115. Wong ZY, Tsonis D, van Herwerden L, Raven J, Forbes A, Abramson MJ, Walters EH, Harrap SB. 1997. Linkage analysis of bronchial hypcrreactivity and atopy with chromosome 11q13. Electrophoresis 18:1641-45
116. Thomas NS, Wilkinson J, Holgate ST. 1997. The candidate region approach to the genetics of asthma and allergy. Am. J. Respir. Crit. Care Med. 156:S144-51
117. Folster-Holst R, Moises HW, Yang L, Fritsch W, Weissenbach J, Christophers E. 1998. Linkage between atopy and the IgE high-affinity receptor gene at 11q13 in atopic dermatitis families. Hum. Genet. 102:236-39
118. Amelung PJ, Postma DS, Xu J, Meyers DA, Bleecker ER. 1998. Exclusion of chromosome 11q and the Fc epsilon RI-beta gene as aetiological factors in allergy and asthma in a population of Dutch asthmatic families. Clin. Exp. Allergy 28:397-403. In press
119. Kuster H, Zhang L, Brini AT, Mac-Glashan DW, JP Kinet. 1992. The gene and cDNA for the human high affinity immunoglobulin E receptor beta chain and expression of the complete human receptor. J. Biol. Chem. 267:12782-87
120. Hill MR, Cookson WO. 1996. A new variant of the beta subunit of the high-affinity receptor for immunoglobulin E (Fc epsilon RI-beta E237G): associations with measures of atopy and bronchial hyper-responsiveness. Hum. Mol. Genet. 5:959-62
121. Hill MR, James AL, Faux JA, Ryan G, Hopkin JM, le Souef P, Musk AW, Cookson WO. 1995. Fc epsilon RI-beta polymorphism and risk of atopy in a general population sample [see comments] [published erratum appears in Br. Med. J. 1995 Nov 4; 311(7014):1196]. Br. Med. J. 311:776-79
122. Shirakawa T, Li A, Dubowitz M, Dekker JW, Shaw AE, Faux JA, Ra C, Cookson WO, Hopkin JM. 1994. Association between atopy and variants of the beta subunit of the high-affinity immunoglobulin E receptor [see comments]. Nat. Genet. 7:125-29
123. Hijazi Z, Haider MZ, Khan MR, Al-Dowaisan AA. 1998. High frequency of IgE receptor Fc epsilon RI beta variant (Leu181/Leu183) in Kuwaiti Arabs and its association with asthma. Clin. Genet. 53:149-52. In press
124. Palmer LJ, Pare PD, Faux JA, Moffatt MF, Daniels SE, LeSouef PN, Bremner PR, Mockford E, Gracey M, Spargo R, Musk AW, Cookson WO. 1997. Fc epsilon R1-beta polymorphism and total serum IgE levels in endemically parasitized Australian aborigines. Am. J. Hum. Genet. 61:182-88
125. Cox HE, Moffatt MF, Faux JA, Walley AJ, Coleman R, Trembath RC, Cookson WO, Harper JI. 1998. Association of atopic dermatitis to the beta subunit of the high affinity immunoglobulin E receptor. Br. J. Dermatol. 138:182-87
126. Hide M, Francis DM, Grattan CE, Hakimi J, Kochan JP, Greaves MW. 1993. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria [see comments]. N. Engl. J. Med. 328:1599-1604
127. Gruber BL, Baeza ML, Marchesc MJ, Agnello V, Kaplan AP. 1988. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J. Invest. Dermatol. 90:213-17
128. Grattan CE, Francis DM, Hide M, Greaves MW. 1991. Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria. Clin. Exp. Allergy 21:695-704
129. Fiebiger E, Maurer D, Holub H, Reininger B, Hartmann G, Woisetschlager M, Kinet JP, Stingl G. 1995. Serum IgG autoantibodies directed against the alpha chain of Fc epsilon RI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients? J. Clin. Invest. 96:2606-12
130. Marone G, Casolaro V, Paganelli R, Quinti I. 1989. IgG anti-IgE from atopic dermatitis induces mediator release from basophils and mast cells. J. Invest. Dermatol. 93:246-52
131. Niimi N, Francis DM, Kermani F, O'Donnell BF, Hide M, Kobza-Black A, Winkelmann RK, Greaves MW, Barr RM. 1996. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J. Invest. Dermatol. 106:1001-6
132. Tong LJ, Balakrishnan G, Kochan JP, Kinet JP, Kaplan AP. 1997. Assessment of autoimmunity in patients with chronic urticaria. J. Allergy Clin. Immunol. 99:461-65
133. Daeron M, Latour S, Malbec O, Espinosa E, Pina P, Pasmans S, Fridman WH. 1995. The same tyrosine-based inhibition motif, in the intracytoplasmic domain of Fc gamma RIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity 3:635-46
134. Cambier JC. 1995. New nomenclature for the Reth motif (orARH1/ TAM/ARAM/YXXL) [letter]. Immunol. Today. 16:110
135. Reth M. 1989. Antigen receptor tail clue [letter]. Nature 338:383-84
136. Irving BA, Weiss A. 1991. The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways. Cell 64:891-901
137. Romeo C, Seed B. 1991. Cellular immunity to HIV activated by CD4 fused to T cell or Fc receptor polypeptides. Cell 64:1037-46
138. Letourneur F, Klausner RD. 1991. T-cell and basophil activation through the cytoplasmic tail of T-cell-receptor zeta family proteins. Proc. Natl. Acad. Sci. USA 88:8905-9
139. Romeo C, Amiot M, Seed B. 1992. Sequence requirements for induction of cytolysis by the T cell antigen/Fc receptor zeta chain. Cell 68:889-97
140. Daeron M. 1997. Fc receptor biology. Annu. Rev. Immunol. 15:203-34
141. Holowka D, Baird B. 1996. Antigen-mediated IGE receptor aggregation and signaling: a window on cell surface structure and dynamics. Annu. Rev. Biophys. Biomol. Struct. 25:79-112
142. Metzger H, Goldstein B, Kent U, Mao SY, Pribluda C, Pribluda V, Wofsy C, Yamashita T. 1994. Quantitative aspects of receptor aggregation. Adv. Exp. Med. Biol. 365:175-83
143. Metzger H. 1992. The receptor with high affinity for IgE. Immunol. Rev. 125:37-48
144. Perez-Montfort R, Fewtrell C, Metzger H. 1983. Changes in the receptor for immunoglobulin E coincident with receptor-mediated stimulation of basophilic leukemia cells. Biochemistry 22:5733-37
145. Quarto R, Metzger H. 1986. The receptor for immunoglobulin E: examination for kinase activity and as a substrate for kinases. Mol. Immunol. 23:1215-23
146. Paolini R, Jouvin MH, Kinet JP. 1991. Phosphorylation and dephosphorylation of the high-affinity receptor for immunoglobulin E immediately after receptor engagement and disengagement. Nature 353:855-58
147. Eiseman E, Bolen JB. 1992. Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinases. Nature 355:78-80
148. Benhamou M, Stephan V, Robbins KC, Siraganian RP. 1992. High-affinity IgE receptor-mediated stimulation of rat basophilic leukemia (RBL-2H3) cells induces early and late protein-tyrosine phosphorylations. J. Biol. Chem. 267: 7310-14
149. Stephan V, Benhamou M, Gutkind JS, Robbins KC, Siraganian RP. 1992. Fc epsilon RI-induced protein tyrosine phosphorylation of pp72 in rat basophilic leukemia cells (RBL-2H3). Evidence for a novel signal transduction pathway unrelated to G protein activation and phosphatidylinositol hydrolysis. J. Biol. Chem. 267:5434-41
150. Hutchcroft JE, Geahlen RL, Deanin GG, Oliver JM. 1992. Fc epsilon RI-mediated tyrosine phosphorylation and activation of the 72-kDa protein-tyrosine kinase, PTK72, in RBL-2H3 rat tumor mast cells. Proc. Natl. Acad. Sci. USA 89:9107-11
151. Pribluda VS, Metzger H. 1992. Transmembrane signaling by the high-affinity IgE receptor on membrane preparations. Proc. Natl. Acad. Sci. USA 89:11446-50
152. Benhamou M, Ryba NJ, Kihara H, Nishikata H, Siraganian RP. 1993. Protein-tyrosine kinase p72syk in high affinity IgE receptor signaling. Identification as a component of pp72 and association with the receptor gamma chain after receptor aggregation. J. Biol. Chem. 268:23318-24
153. Moran MF, Koch CA, Anderson D, Ellis C, England L, Martin GS, Pawson T. 1990. Src homology region 2 domains direct protein-protein interactions in signal transduction. Proc. Natl. Acad. Sci. USA 87:8622-26
154. Zhou S, Cantley LC. 1995. SH2 domain specificity determination using oriented phosphopeptide library. Meth. Enzymol. 254:523-35
155. Weiss A, Littman DR. 1994. Signal transduction by lymphocyte antigen receptors. Cell 76:263-74
156. Bu JY, Shaw AS, Chan AC. 1995. Analysis of the interaction of ZAP-70 and syk protein-tyrosine kinases with the T-cell antigen receptor by plasmon resonance. Proc. Natl. Acad. Sci. USA 92:5106-10
157. Cambier JC. 1995. Antigen and Fc receptor signaling. The awesome power of the immunoreceptor tyrosine-based activation motif (ITAM). J. Immunol. 155:3281-85
158. Chen T, Repetto B, Chizzonite R, Pullar C, Burghardt C, Dharm E, Zhao Z, Carroll R, Nunes P, Basu M, Danho W, Visnick M, Kochan J, Waugh D, Gilfillan AM. 1996. Interaction of phosphorylated Fc epsilon RI gamma immunoglobulin receptor tyrosine activation motif-based peptides with dual and single SH2 domains of p72syk. Assessment of binding parameters and real time binding kinetics. J. Biol. Chem. 271:25308-15
159. Kihara H, Siraganian RP. 1994. Src homology 2 domains of Syk and Lyn bind to tyrosine-phosphorylated subunits of the high affinity IgE receptor. J. Biol. Chem. 269:22427-32
160. Shiue L, Zoller MJ, Brugge JS. 1995. Syk is activated by phosphotyrosine-containing peptides representing the tyrosine-based activation motifs of the high affinity receptor for IgE. J. Biol. Chem. 270:10498-502
161. Rivera VM, Brugge JS. 1995. Clustering of Syk is sufficient to induce tyrosine phosphorylation and release of allergic mediators from rat basophilic leukemia cells. Mol. Cell. Biol. 15:1582-90
162. Hirasawa N, Scharenberg A, Yamamura H, Beaven MA, Kinet JP. 1995. A requirement for Syk in the activation of the microtubule-associated protein kinase/phospholipase A2 pathway by Fc epsilon R1 is not shared by a G protein-coupled receptor. J. Biol. Chem. 270:10960-67
163. Scharenberg AM, Lin S, Cuenod B, Yamamura H, Kinet JP. 1995. Reconstitution of interactions between tyrosine kinases and the high affinity IgE receptor which are controlled by receptor clustering. Embo J. 14:3385-94
164. Oliver JM, Burg DL, Wilson BS, McLaughlin JL, Geahlen RL. 1994. Inhibition of mast cell Fc epsilon R1-mediated signaling and effector function by the Syk-selective inhibitor, piceatannol. J. Biol. Chem. 269:29697-703
165. Valle A, Kinet JP. 1995. N-acetyl-Lcysteine inhibits antigen-mediated Syk, but not Lyn tyrosine kinase activation in mast cells. FEBS Lett. 357:41-44
166. Letourneur F, Klausner RD. 1992. Activation of T cells by a tyrosine kinase activation domain in the cytoplasmic tail of CD3 epsilon. Science 255:79-82
167. Adamczewski M, Paolini R, Kinet JP. 1992. Evidence for two distinct phosphorylation pathways activated by high affinity immunoglobulin E receptors. J. Biol. Chem. 267:18126-32
168. Eiseman E, Bolen JB. 1992. Signal transduction by the cytoplasmic domains of Fc epsilon RI-gamma and TCR-zeta in rat basophilic leukemia cells. J. Biol. Chem. 267:21027-32
169. Jouvin MH, Adamczewski M, Numerof R, Letourneur O, Valle A, Kinet JP. 1994. Differential control of the tyrosine kinases Lyn and Syk by the two signaling chains of the high affinity immunoglobulin E receptor. J. Biol. Chem. 269:5918-25
170. Wilson BS, Kapp N, Lee RJ, Pfeiffer Jr, Martinez AM, Platt Y, Letourneur F, Oliver JM. 1995. Distinct functions of the Fc epsilon R1 gamma and beta subunits in the control of Fc epsilon R1-mediated tyrosine kinase activation and signaling responses in RBL-2H3 mast cells. J. Biol. Chem. 270:4013-22
171. Shiue L, Green J, Green OM, Karas JL, Morgenstern JP, Ram MK, Taylor MK, Zoller MJ, Zydowsky LD, Bolen JB, et al. 1995. Interaction of p72syk with the gamma and beta subunits of the high-affinity receptor for immunoglobulin E, Fc epsilon RI. Mol. Cell. Biol. 15:272-81
172. Jabril-Cuenod B, Zhang C, Scharenberg AM, Paolini R, Numerof R, Beaven MA, Kinet JP. 1996. Syk-dependent phosphorylation of She. A potential link between Fc epsilon RI and the Ras/mitogen-activated protein kinase signaling pathway through SOS and Grb2. J. Biol. Chem. 271:16268-72
173. Nishizumi H, Yamamoto T. 1997. Impaired tyrosine phosphorylation and Ca2+ mobilization, but not degranulation, in lyn-deficient bone marrow-derived mast cells. J. Immunol. 158:2350-55
174. Costello PS, Turner M, Walters AE, Cunningham CN, Bauer PH, Downward J, Tybulewicz VL. 1996. Critical role for the tyrosine kinase Syk in signalling through the high affinity IgE receptor of mast cells. Oncogene 13:2595-605
175. Zhang J, Berenstein EH, Evans RL, Siraganian RP. 1996. Transfection of Syk protein tyrosine kinase reconstitutes high affinity IgE receptor-mediated degranulation in a Syk-negative variant of rat basophilic leukemia RBL-2H3 cells. J. Exp. Med. 184:71-9
176. Osborne MA, Zcnncr G, Lubinus M, Zhang X, Songyang Z, Cantlcy LC, Majerus P, Burn P, Kochan JP. 1996. The inositol 5′-phosphatase SHIP binds to immunoreceptor signaling motifs and responds to high affinity IgE receptor aggregation. J. Biol. Chem. 271:29271-78
177. Kimura T, Zhang J, Sagawa K, Sakaguchi K, Appella E, Siraganian RP. 1997. Syk-independent tyrosine phosphorylation and association of the protein tyrosine phosphatases SHP-1 and SHP-2 with the high affinity IgE receptor. J. Immunol. 159:4426-34
178. Kimura T, Sakamoto H, Appella E, Siraganian RP. 1997. The negative signaling molecule SH2 domain-containing inositol-polyphosphate 5-phosphatase (SHIP) binds to thetyrosine-phosphorylated beta subunit of the high affinity IgE receptor. J. Biol. Chem. 272: 13991-96
179. Ottinger EA, Botfield MC, Shoelson SE, 1998. Tandem SH2 domains confer high specificity in tyrosine kinase signaling. J. Biol Chem. 273:729-35
180. Vonakis BM, Chen H, Haleem-Smith H, Metzger H. 1997. The unique domain as the site on Lyn kinase for its constitutive association with the high affinity receptor for IgE. J. Biol. Chem. 272:24072-80
181. Stauffer TP, Martenson CH, Rider JE, Kay BK, Meyer T. 1997. Inhibition of Lyn function in mast cell activation by SH3 domain binding peptides. Biochemistry 36:9388-94
182. El-Hillal O, Kurosaki T, Yamamura H, Kinet JP, Scharenberg AM. 1997. Syk kinase activation by a src kinase-initiated activation loop phosphorylation chain reaction. Proc. Natl. Acad. Sci. USA 94: 1919-24
183. Trowbridge IS, Thomas ML. 1994. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu. Rev. Immunol. 12:85-116
184. Hook WA, Berenstein EH, Zinsser FU, Fischler C, Siraganian RP. 1991. Monoclonal antibodies to the leukocyte common antigen (CD45) inhibit IgE-mediated histamine release from human basophils. J. Immunol. 147:2670-76
185. Adamczewski M, Numerof RP, Koretzky GA, Kinet JP. 1995. Regulation by CD45 of the tyrosine phosphorylation of high affinity IgE receptor beta-and gamma-chains. J. Immunol. 154:3047-55
186. Pribluda VS, Pribluda C, Metzger H. 1994. Transphosphorylation as the mechanism by which the high-affinity receptor for IgE is phosphorylated upon aggregation. Proc. Natl. Acad. Sci. USA 91:11246-50
187. Yamashita T, Mao SY, Metzger H. 1994. Aggregation of the high-affinity IgE receptor and enhanced activity of p53/56 lyn protein-tyrosine kinase. Proc. Natl. Acad. Sci. USA 91:11251-55
188. Torigoe C, Goldstein B, Wofsy C, Metzger H. 1997. Shuttling of initiating kinase between discrete aggregates of the high affinity receptor for IgE regulates the cellular response. Proc. Natl. Acad. Sci. USA 94:1372-77
189. Torigoe C, Inman JK, Metzger H. 1998. An unusual mechanism for ligand antagonism. Science 281:568-72
190. Tsukada S, Saffran DC, Rawlings DJ, Parolini O, Allen RC, Klisak I, Sparkes RS, Kubagawa H, Mohandas T, Quan S, et al. 1993. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72:279-90
191. Vihinen M, Vetrie D, Maniar HS, Ochs HD, Zhu Q, Vorechovsky I, Webster AD, Notarangelo LD, Nilsson L, Sowadski JM, et al. 1994. Structural basis for chromosome X-linked agammaglobulinemia: a tyrosine kinase disease. Proc. Natl. Acad. Sci. USA 91:12803-7
192. Desiderio S, Siliciano JD. 1994. The Itk/Btk/Tec family of protein-tyrosine kinases. Chem. Immunol. 59:191-210
193. Tsukada S, Rawlings DJ, Witte ON. 1994. Role of Bruton's tyrosine kinase in immunodeficiency. Curr. Optn. Immunol. 6:623-30
194. Rawlings DJ, Witte ON. 1994. Bruton's tyrosine kinase is a key regulator in B-cell development. Immunol. Rev. 138:105-19
195. Rawlings DJ, Saffran DC, Tsukada S, Largaespada DA, Grimaldi JC, Cohen L, Mohr RN, Bazan JF, Howard M, Copeland NG, et al. 1993. Mutation of unique region of Bruton's tyrosinekinase in immunodeficient XID mice. Science 261:358-61
196. Thomas JD, Sideras P, Smith CI, Vorechovsky I, Chapman V, Paul WE. 1993. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science 261:355-68
197. Hata D, Kawakami Y, Inagaki N, Lantz CS, Kitamura T, Khan WN, Maeda-Yamamoto M, Miura T, Han W, Hartman SE, Yao L, Nagai H, Goldfeld AE, Alt FW, Galli SJ, Witte ON, Kawakami T. 1998. Involvement of Bruton's tyrosine kinase in Fc epsilon RI-dependent mast cell degranulation and cytokine production. J. Exp. Med. 187:1235-47
198. Hata D, Kitaura J, Hartman SE, Kawakami Y, Yokota T, Kawakami T. 1998. Bruton's tyrosine kinase-mediated interleukin-2 gene activation in mast cells. Dependence on the c-Jun N-terminal kinase activation pathway. J. Biol. Chem. 273:10979-87
199. Kawakami Y, Yao L, Miura T, Tsukada S, Witte ON, Kawakami T. 1994. Tyrosine phosphorylation and activation of Bruton tyrosine kinase upon Fc epsilon RI cross-linking. Mol. Cell. Biol. 14:5108-13
200. Takata M, Kurosaki T. 1996. A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-gamma 2. J. Exp. Med. 184:31-40
201. Rawlings DJ, Scharenberg AM, Park H, Wahl MI, Lin S, Kato RM, Fluckiger AC, Witte ON, Kinet JP. 1996. Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases. Science 271:822-25
202. Salim K, Bottomley MJ, Querfurth E, Zvelebil MJ, Gout I, Scaife R, Margolis RL, Gigg R, Smith CI, Driscoll PC, Waterfield MD, Panayotou G. 1996. Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase. Embo J. 15:6241-50
203. Rameh LE, Arvidsson A, Carraway KL 3rd, Couvillon AD, Rathbun G, Crompton A, Van Renterghem B, Czech MP, Ravichandran KS, Burakoff SJ, Wang DS, Chen CS, Cantley LC. 1997. A comparative analysis of the phosphoinositide binding specificity of pleckstrin homology domains. J. Biol. Chem. 272:22059-66
204. Carpenter CL, Cantley LC. 1996. Phosphoinositide kinases. Curr. Opin. Cell Biol. 8:153-58
205. Vanhaesebroeck B, Leevers SJ, Panayotou G, Waterfield MD. 1997. Phosphoinositide 3-kinases: a conserved family of signal transducers. Trends Biochem. Sci. 22:267-72
206. Yano H, Nakanishi S, Kimura K, Hanai N, Saitoh Y, Fukui Y, Nonomura Y, Matsuda Y. 1993. Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositoI3-kinase in RBL 2H3 cells. J. Biol. Chem. 268:25846-56
207. Yano H, Agatsuma T, Nakanishi S, Saitoh Y, Fukui Y, Nonomura Y, Matsuda Y. 1995. Biochemical and pharmacological studies with KT7692 and LY294002 on the role of phosphatidylinositol 3-kinase in Fc epsilon RI-mediated signal transduction. Biochem J. 312:145-50
208. Barker SA, Caldwell KK, Hall A, Martinez AM, Pfeiffer Jr, Oliver JM, Wilson BS. 1995. Wortmannin blocks lipid and proteinkinase activities associated with PI 3-kinase and inhibits a subset of responses induced by Fc epsilon RI cross-linking. Mol. Cell. Biol. 106:45-58
209. Bolland S, Pearse RN, Kurosaki T, Ravetch JV. 1998. SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity 8:509-16
210. Scharenberg AM, Kinet JP. 1998. PtdIns-3,4,5-P3: a regulatory nexus between tyrosine kinases and sustained calcium signals. Cell 94:5-8. In press
211. Scharenberg AM, El-Hillal O, Fruman DA, Beitz LO, Li Z, Lin S, Gout I, Cantley LC, Rawlings DJ, Kinet JP. 1998. PhosphatidylinositoI-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Teckinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. Embo J. 17:1961-72
212. Fluckiger AC, Li Z, Kato RM, Wahl MI, Ochs HD, Longnecker R, Kinet JP, Witte ON, Scharenberg AM, Rawlings DJ. 1998. Btk/Teckinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation. Embo. J. 17:1973-85
213. Parckh AB, Fleig A, Penner R. 1997. The store-operated calcium current I(CRAC): nonlinear activation by InsP3 and dissociation from calcium release. Cell 89:973-80
214. Dolmetsch RE, Lewis RS, Goodnow CC, Healy JI. 1997. Differential activation of transcription factors induced by Ca2+ response amplitude and duration [see comments] [published erratum appears in Nature 1997 Jul. 17; 388 (6639):308]. Nature 386:855-58
215. Healy JI, Dolmetsch RE, Timmerman LA, Cyster JG, Thomas ML, Crabtree GR, Lewis RS, Goodnow CC. 1997. Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity 6: 419-28
216. Pleiman CM, Hertz WM, Cambier JC. 1994. Activation of phosphatidylinositol-3′ kinase by Src-family kinase SH3 binding to the p85 subunit. Science 263:1609-12
217. Spiegel S, Merrill AH Jr. 1996. Sphingolipid metabolism and cell growth regulation. Faseb J. 10:1388-97
218. Spiegel S, Cuvillier O, Edsall LC, Kohama T, Menzeleev R, Olah Z, Olivera A, Pirianov G, Thomas DM, Tu Z, Van Brocklyn Jr, Wang F. 1998. Sphingosine-1-phosphate in cell growth and cell death. Ann. N. Y. Acad. Sci. 845:11-18
219. Van Brocklyn Jr, Lee MJ, Menzeleev R, Olivera A, Edsall L, Cuvillier O, Thomas DM, Coopman PJP, Thangada S, Liu CH, Hla T, Spiegel S. 1998. Dual actions of sphingosine-1-phosphate: extracellular through the Gi-coupled receptor edg-1 and intracellular to regulate proliferation and survival. J. Cell. Biol. 142:229-40
220. Olivera A, Spiegel S. 1993. Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature 365:557-60
221. Olivera A, Kohama T, Tu Z, Milstien S, Spiegel S. 1998. Purification and characterization of rat kidney sphingosinekinase. J. Biol. Chem. 273:12576-83
222. Buehrer BM, Bell RM. 1993. Sphingosine kinase: properties and cellular functions. Adv. Lipid Res. 26:59-67
223. Ghosh TK, Bian J, Gill DL. 1994. Sphingosine 1-phosphate generated in the endoplasmic reticulum membrane activates release of stored calcium. J. Biol. Chem. 269:22628-35
224. Kim S, Lakhani V, Costa DJ, Sharara AI, Fitz JG, Huang LW, Peters KG, Kindman LA. 1995. Sphingolipid-gated Ca2+ release from intracellular stores of endothelial cells is mediated by a novel Ca(2+)-permeable channel. J. Biol. Chem. 270:5266-69
225. Mattie M, Brooker G, Spiegel S. 1994. Sphingosine-1-phosphate, a putative second messenger, mobilizes calcium from internal stores via an inositoltrisphosphate-independent pathway. J. Biol. Chem. 269:3181-88
226. Choi OH, Lee JH, Kassessinoff T, Cunha-Melo Jr, Jones SV, Beaven MA. 1993. Antigen and carbachol mobilize calcium by similar mechanisms in a transfected mast cell line (RBL-2H3 cells) that expresses ml muscarinic receptors. J. Immunol. 151:5586-95
227. Jones SV, Choi OH, Beaven MA. 1991. Carbachol induces secretion in a mast cell line (RBL-2H3) transfected with the ml muscarinic receptor gene. FEBS Lett. 289:47-50
228. Buehrer BM, Bell RM. 1992. Inhibition of sphingosine kinase in vitro and in platelets. Implications for signal transduction pathways. J. Biol. Chem. 267:3154-59
229. Choi OH, Kim JH, Kinet JP. 1996. Calcium mobilization viasphingosine kinase in signalling by the Fc epsilon RI antigen receptor. Nature 380:634-36
230. Wu J, Spiegel S, Sturgill TW. 1995. Sphingosine-1-phosphate rapidly activates the mitogen-activated protein kinase pathway by a G protein-dependent mechanism. J. Biol. Chem. 270:11484-88
231. Goodemote KA, Mattie ME, Berger A, Spiegel S. 1995. Involvement of a pertussis toxin-sensitive G protein in the mitogenic signaling pathways of sphingosine 1-phosphate. J. Biol. Chem. 270:10272-77
232. Lee MJ, Van Brocklyn Jr, Thangada S, Liu CH, Hand AR, Menzeleev R, Spiegel S, Hla T. 1998. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 279:1552-55
233. Matthews G, Neher E, Penner R. 1989. Second messenger-activated calcium influx in rat peritoneal mast cells. J. Physiol. 418:105-30
234. Meyer T, Holowka D, Stryer L. 1988. Highly cooperative opening of calcium channels by inositol 1,4,5-trisphosphate. Science 240:653-56
235. Saito H, Ishizaka K, Ishizaka T. 1989. Effect of nonhydrolyzable guanosinc phosphate on IgE-mediated activation of phospholipase C and histamine release from rodent mast cells. J. Immunol. 143:250-58
236. Melendez A, Floto RA, Gillooly DJ, Harnett MM, Allen JM. 1998. Fc gammaRI coupling to phospholipase D initiates sphingosine kinase-mediated calcium mobilization and vesicular trafficking. J. Biol. Chem. 273:9393-402
237. Mathes C, Fleig A, Penner R. 1998. Calcium-release-activated calcium current (ICRAC) is a direct -target for sphingosine. J. Biol. Chem. 273:25020-30
238. Pribluda VS, Pribluda C, Metzger H. 1997. Biochemical evidence that the phosphorylated tyrosines, serines, and threonines on the aggregated high affinity receptor for IgE are in the immunoreceptor tyrosine-based activation motifs. J. Biol. Chem. 272:11185-92
239. Germano P, Gomez J, Kazanietz MG, Blumberg PM, Rivera. J. 1994. Phosphorylation of the gamma chain of the high affinity receptor for immunoglobulin E by receptor-associated proteinkinase C-delta. J. Biol. Chem. 269:23102-7
240. Razin E, Szallasi Z, Kazanietz MG, Blumberg PM, Rivera J. 1994. Proc. Natl. Acad. Sci. USA 91:7722-26
241. Chang EY, Szallasi Z, Acs P, Raizada V, Wolfe PC, Fewtrell C, Blumberg PM, Rivera J. 1997. Functional effects of overexpression of protein kinase C-alpha, -beta, - delta, -epsilon, and -eta in the mast cell line RBL-2H3. J. Immunol. 159:2624-32
242. Mao SY, Metzger H. 1997. Characterization of protein-tyrosine phosphatases that dephosphorylate the high affinity IgE receptor [published erratum appears in J. Biol. Chem. 1997 Sep. 19; 272(38):24096]. J. Biol. Chem. 272: 14067-73
243. Teramoto H, Salem P, Robbins KC, Bustelo XR, Gutkind JS. 1997. Tyrosine phosphorylation of the vav protooncogene product links Fc epsilon RI to the Rac1-JNK pathway. J. Biol. Chem. 272:10751-55
244. Margolis B, Hu P, Katzav S, Li W, Oliver JM, Ullrich A, Weiss A, Schlessinger J. 1992. Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs [see comments]. Nature 356:71-74
245. Song JS, Gomez J, Stancato LF, Rivera J. 1996. Association of a p95 Vav-containing signaling complex with the Fcepsilon RI gamma chain in the RBL-2H3 mast cell line. Evidence for a constitutive in vivo association of Vav with Grb2, Raf-1, and ERK2 in an active complex. J. Biol. Chem. 271:26962-70
246. Jackman JK, Motto DC, Sun Q, Tanemoto M, Turek CW, Peltz GA, Koretzky GA, Findell PR. 1995. Molecular cloning of SLP-76, a 76-kDa tyrosine phosphoprotein associated with Grb2 in T cells. J. Biol. Chem. 270:7029-32
247. Hendricks-Taylor LR, Motto DG, Zhang J, Siraganian RP, Koretzky GA. 1997. SLP-76 is a substrate of the high affinity IgE receptor-stimulated protein tyrosine kinases in rat basophilic leukemia cells. J. Biol. Chem. 272:1363-67
248. Yablonski D, Kuhne MR, Kadlecek T, Weiss A. 1998. Uncoupling of nonreceptor tyrosine kinases from PLC-gamma I in an SLP-76-deficient T cell. Science 281:413-16
249. Clements JL, Yang B, Ross-Barta SE, Eliason SL, Hrstka RF, Williamson RA, Koretzky GA. 1998. Requirement for the leukocyte-specific adapter protein SLP-76 for normal T cell development. Science 281:416-19
250. Pivniouk V, Tsitsikov E, Swinton P, Rathbun G, Alt FW, Geha RS. 1998. Impaired viability and profound block in thymocyte development in mice lacking the adaptor protein SLP-76. Cell 94:229-38
251. Ota Y, Beitz LO, Scharenberg AM, Donovan JA, Kinet JP, Samelson LE. 1996. Characterization of Cbl tyrosine phosphorylation and a Cbl-Syk complex in RBL-2H3 cells. J. Exp. Med. 184:1713-23